These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6292626)

  • 1. Recognition of opioid agonist and antagonist in the opioid receptor binding site.
    Nozaki M; Niwa M; Hasegawa J; Imai E; Hori M; Fujimura H
    Life Sci; 1982 Sep 20-27; 31(12-13):1339-42. PubMed ID: 6292626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of opioid receptor binding; possible mechanisms of sulfhydryl groups in the binding site.
    Niwa M; Nozaki M; Fujimura H
    Life Sci; 1983; 33 Suppl 1():211-4. PubMed ID: 6319863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 5,5'-dithiobis-(2-nitrobenzoic acid) on opiate binding to both the membrane-bound receptor and the partially purified opiate receptor.
    Nozaki M; Cho TM
    J Neurochem; 1985 Aug; 45(2):461-4. PubMed ID: 2989428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative properties of SH-groups at mu, delta and kappa opioid receptor.
    Nozaki M; Niwa M; Fujimura H
    NIDA Res Monogr; 1986; 75():149-52. PubMed ID: 2828961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICI 154,129, a delta-opioid receptor antagonist raises seizure threshold in rats.
    Tortella FC; Robles LE; Holaday JW; Cowan A
    Eur J Pharmacol; 1984 Jan; 97(1-2):141-4. PubMed ID: 6321207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-funaltrexamine on radiolabeled opioid binding.
    Recht LD; Pasternak GW
    Eur J Pharmacol; 1987 Aug; 140(2):209-14. PubMed ID: 2822439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.
    Gioannini TL; Onoprishvili I; Hiller JM; Simon EJ
    Neurochem Res; 1999 Jan; 24(1):37-42. PubMed ID: 9973235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons.
    Adams DJ; Trequattrini C
    J Neurophysiol; 1998 Feb; 79(2):753-62. PubMed ID: 9463438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Opioid receptor interactions of butorphanol, a narcotic antagonist analgesic, and its metabolites].
    Nozaki M; Niwa M; Hasegawa J; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Dec; 82(6):443-50. PubMed ID: 6321306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of rabbit ear artery opioid receptors using a delta-selective agonist and antagonist.
    Berzetei IP; Yamamura HI; Duckles SP
    Eur J Pharmacol; 1987 Jul; 139(1):61-6. PubMed ID: 2820755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone-induced opiate receptor supersensitivity.
    Zukin RS; Sugarman JR; Fitz-Syage ML; Gardner EL; Zukin SR; Gintzler AR
    Brain Res; 1982 Aug; 245(2):285-92. PubMed ID: 6289965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific opiate binding in living human polymorphonuclear leucocytes.
    Falke NE; Fischer EG; Martin R
    Cell Biol Int Rep; 1985 Nov; 9(11):1041-7. PubMed ID: 2866037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.